Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-06

Clinical Trial Update: Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of virgin coconut oil on cardiometabolic parameters in patients with dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Virgin Coconut Oil

Snippet

Sponsor: All India Institute of Medical Sciences, Bhubaneswar | Conditions: Dyslipidemias | Phase 4 | Status: COMPLETED